ONPH is exploring strategic partnerships and opportunities in oncology

Our Portfolio (Licences - LOI)

Nanosmart Pharmaceuticals  -  
NanoSmart's® platform technology  (US  Patent No: 7,799,327 and EU 1706145 B1)

​

​

Diagnomics Inc.

​

​

​

Connect2Med

​

​

Kalos Therapeutics  -   

KTH-222

​

​

​

​

​

​

​

​

Licences